GERD: Clinical Trials

26 trials for GERD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

17 completed, 4 unknown, 2 recruiting, 2 withdrawn. 26 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 426Completed 17, Unknown 4, Recruiting 2, Withdrawn 2, Terminated 1

Follow GERD: new trials by email Literature Review of GERD trials Research Report on GERD

Trials (filtered) newest first · largest first

All 26 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Heartburn, Gastroesophageal Reflux Disease
Zastaprazan, Esomeprazole - GERD
Phase 4RecruitingIncheon St.Mary's Hospital1602025-07-072025-12-23
Famotidine and Antacids for Treatment of Dyspepsia
Intravenous Famotidine, Oral Maalox/ Mylanta - Dyspepsia, GERD
Phase 4RecruitingStony Brook University802023-11-092026-06-02
Citalopram for Reflux Hypersensitivity and Functional Heartburn
Citalopram 20mg, Placebo Oral Tablet - GERD
Phase 4UnknownUniversitaire Ziekenhuizen KU Leuven1002019-05-272019-12-05
Effectiveness of Vonoprazan vs Omeprazole as Empiric Therapy for Gastroesophageal Reflux Disease (GERD) Patients Without Alarm Features
Vonoprazan, Omeprazole - GERD, Gastro Esophageal Reflux
Phase 4TerminatedSt. Luke's Medical Center, Philippines822019-05-262023-11-22
Prucalopride Treatment for Refractory Gastro-esophageal Reflux Disease
Prucalopride, Placebo Oral Tablet - GERD
Phase 4UnknownUniversitaire Ziekenhuizen KU Leuven602019-02-182019-12-05
Effect of Obesity on Proton Pump Inhibitors
Lansoprazole, Pantoprazole, Midazolam - Pediatric Obesity, NAFLD
Phase 4CompletedChildren's Mercy Hospital Kansas City762018-07-032026-06-04
Cardiac Safety of Lansoprazole and Domperidon Combination
Lansoprazole/Domperidone, Lansoprazole - GERD, Cardiac Event
Phase 4WithdrawnNeutec Ar-Ge San ve Tic A.Ş2018-03-012023-01-05
Efficacy and Safety Evaluation of Neobianacid® in GERD and EPS
Neobianacid®, Omeprazole 20mg, Neobianacid® placebo - GERD, EPS
Phase 4CompletedAboca Spa Societa' Agricola2752017-09-122022-11-21
An Open-Label Trial of Dexlansoprazole 60mg for the Relief of Heartburn During the Fasting Month of Ramadan
Dexlansoprazole 60 MG - GERD, Proton Pump Inhibitor
Phase 4CompletedAmerican University of Beirut Medical Center332017-02-272017-09-15
The Relationship Between Gastroesophageal Reflux and Pediatric Rhinitis: Significance of Pale/Blue Colored Turbinate
lansoprazole, placebo - Rhinitis, Nasal Obstruction
Phase 4UnknownMcGill University Health Centre/Research Institute of the McGill University Health Centre982015-01-012014-10-29
Research of Efficient Use of Omeprazole in Combination With Domperidone in Gastroesophageal Reflux Disease of Mild to Moderate Severity
omeprazole+domperidone SR, omeprazole - GERD
Phase 4UnknownBelarusian Medical Academy of Post-Graduate Education602013-12-012014-05-16
Efficacy and Saafety of Omez Iin Patients With H.Pylori Associated Diseases
OMEZ 40, OMEZ 80 - GERD
Phase 4CompletedDr. Reddy's Laboratories Limited1202013-01-012016-10-04
To Assess the Efficacy of Esomeprazole 20mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole
esomeprazole 20 mg - Gastroesophageal Reflux Disease, GERD
Phase 4CompletedAstraZeneca1072011-08-012013-02-21
Placebo Controlled Study of Baclofen for GERD in Children With Cerebral Palsy
Baclofen, placebo - Cerebral Palsy, GERD
Phase 4WithdrawnBoston Children's Hospital2009-04-012017-08-29
Does Omeprazole Decrease Intestinal Calcium Absorption?
Omeprazole - Osteoporosis, Achlorhydria
Phase 4CompletedUniversity of Wisconsin, Madison232008-01-012013-02-15
Nexium (Esomeprazole) in Symptom Adapted Therapy in GERD Patients
esomeprazole (Nexium®), Xolaam® - GERD
Phase 4CompletedAstraZeneca30292007-03-012012-12-11
Nexium RESPONSE Trial
Esomeprazole - GERD
Phase 4CompletedAstraZeneca10002006-05-012009-01-26
Nexium 40mg Once Daily vs Prevacid 30mg Twice a Day for Control of Severe GERD
Antacids - GERD
Phase 4CompletedDigestive & Liver Disease Specialists502005-10-012009-02-25
An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD)
Esomeprazole - GERD
Phase 4CompletedAstraZeneca3502005-10-012009-03-06
The Utility of Nexium in Chronic Cough and Reflux Disease
Esomeprazole, Placebo - Cough, GERD
Phase 4CompletedUniversity of North Carolina, Chapel Hill402005-09-012012-01-10

Showing 20 of 26. Sign in to see all of them.

Narrower conditions

Gastroesophageal Reflux (26)  ·  Heartburn (3)  ·  Achlorhydria (1)  ·  Cardiovascular Diseases (1)  ·  Cerebral Palsy (1)  ·  Cough (1)  ·  Dyspepsia (1)  ·  Esophagitis (1)  ·  Esophagitis, Peptic (1)  ·  Hip Fractures (1)  ·  Nasal Obstruction (1)  ·  Non-alcoholic Fatty Liver Disease (1)  ·  Osteoporosis (1)  ·  Parasomnias (1)  ·  Pediatric Obesity (1)

Broader conditions

Deglutition Disorders (26)  ·  Digestive System Diseases (26)  ·  Esophageal Diseases (26)  ·  Esophageal Motility Disorders (26)  ·  Gastrointestinal Diseases (26)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Signs and Symptoms (6)  ·  Signs and Symptoms, Digestive (4)  ·  Gastroenteritis (2)  ·  Nervous System Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Respiration Disorders (2)  ·  Respiratory Tract Diseases (2)  ·  Stomach Diseases (2)  ·  Acid-Base Imbalance (1)

Interventions

Esomeprazole (9)  ·  Omeprazole (5)  ·  Lansoprazole (3)  ·  Antacids (2)  ·  Pantoprazole (2)  ·  Rabeprazole (2)  ·  1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine (1)  ·  Ambulatory Care Facilities (1)  ·  Baclofen (1)  ·  Citalopram (1)  ·  Dexlansoprazole (1)  ·  Domperidone (1)  ·  Histamine H2 Antagonists (1)  ·  Midazolam (1)  ·  aluminum hydroxide, magnesium hydroxide, drug combination (1)

Sponsors

AstraZeneca (7)  ·  Universitaire Ziekenhuizen KU Leuven (2)  ·  Aboca Spa Societa' Agricola (1)  ·  American University of Beirut Medical Center (1)  ·  Belarusian Medical Academy of Post-Graduate Education (1)  ·  Boston Children's Hospital (1)  ·  Children's Mercy Hospital Kansas City (1)  ·  Digestive & Liver Disease Specialists (1)  ·  Dr. Reddy's Laboratories Limited (1)  ·  Incheon St.Mary's Hospital (1)  ·  McGill University Health Centre/Research Institute of the McGill University Health Centre (1)  ·  National Taiwan University Hospital (1)  ·  Neutec Ar-Ge San ve Tic A.Ş (1)  ·  St. Luke's Medical Center, Philippines (1)  ·  Stony Brook University (1)

Countries

United States (8)  ·  Belgium (2)  ·  Belarus (1)  ·  Denmark (1)  ·  France (1)  ·  Italy (1)  ·  Lebanon (1)  ·  Netherlands (1)  ·  Philippines (1)  ·  South Korea (1)  ·  Taiwan (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Top investigators

Nicholas Shaheen, MD, MPH (2)  ·  David A Johnson, MD (1)  ·  Karen E Hansen, MD (1)  ·  Kathryn Kyler, MD, MS (1)  ·  Makiko Abe (1)  ·  Masataka Date (1)  ·  Ming-Shiang Wu, PHD (1)  ·  Nicodemus L Ong, MD (1)  ·  Paula Fernstrom (1)  ·  Samuel Nurko, MD (1)  ·  Serhat Bor, Prof Dr (1)

Results publications

PMID 19601705, PMID 20578215, PMID 21083590, PMID 21083673, PMID 21347742, PMID 22759841, PMID 26559637, PMID 28119763, PMID 28567114, PMID 28607547, PMID 28894571, PMID 29739175, PMID 30504527, PMID 30625462, PMID 37307528, PMID 42226497

NIH funding

K23DK115827 (1), R21DK077678 (1)